Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd has announced that its Board of Directors will convene on November 4, 2026. The primary agenda item for this meeting is to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026. Additionally, the company confirmed that the trading window for its securities will remain closed until November 6, 2026, as previously communicated.

Niva Bupa Health Insurance Company Ltd has issued a Call Option Notice to redeem 1,500 unsecured, subordinated, listed, rated, redeemable, non-convertible debentures aggregating ₹150 Crore. The debentures, allotted on November 15, 2021, will be redeemed at par along with accrued interest on November 13, 2026, which is the preceding business day to the official Call Option Date of November 15, 2026. This action is in accordance with the terms of the placement memorandum and debenture trust deed.

Niva Bupa Health Insurance Company Ltd's Debt Raising Committee has approved the exercise of a call option for 1,500 unsecured, subordinated, listed, rated, redeemable, non-convertible debentures worth ₹1,50,00,00,000 (₹150 Crore). The record date for this redemption has been set as November 02, 2026. The debentures, with ISIN INE995S08010, were initially allotted on November 15, 2021. Redemption at par along with interest will occur on November 13, 2026, which is the preceding business day to the original redemption date of November 15, 2026.

Niva Bupa Health Insurance Company Ltd has announced that its Debt Raising Committee of the Board will convene on October 9, 2026. The primary agenda is to consider and approve the redemption of 1,500 unsecured, subordinated, listed, rated, redeemable, non-convertible debentures. These debentures, with a face value of ₹150,00,00,000 (₹150 Crore), were issued on November 15, 2021, and will be redeemed at par. The debenture has ISIN INE995S08010.

Niva Bupa Health Insurance Company Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut from Thursday, October 01, 2026, until 48 hours after the company's unaudited financial results for the quarter and half-year ending September 30, 2026, are made public. The specific date for the board meeting to consider these results will be announced later.

Niva Bupa Health Insurance Company Ltd announced changes in its senior management effective September 16, 2026. Mr. Vikas Jain, previously the Chief Investment Officer since October 2020, will move to the role of Chief Transformation Officer. Concurrently, Mr. Karan Bhatia has been appointed as the new Chief Investment Officer. Mr. Bhatia has been with the company's investment function since December 2015 and brings over a decade of experience in the investment domain.

Niva Bupa Health Insurance Company Ltd has been assigned an ESG rating of ‘67 Leader’ by Niche99 ESG Ratings for FY 2024-25 & FY 2025–26. The rating was assigned independently by Niche99 ESG Ratings, a SEBI-registered provider, based on publicly available information. The company has not engaged Niche99 for this rating. This independent assessment highlights the company's environmental, social, and governance performance.

Niva Bupa Health Insurance Company Ltd has received an order from the IRDAI warning the company for non-compliance with Expense of Management (EoM) limits for FY 2024-25. The regulator has also directed the company to not open any new places of business for a period of six months from August 19, 2026. The company stated it is evaluating the order and will take appropriate steps. Niva Bupa also clarified that it is in compliance with EoM Regulations for FY ended March 31, 2026, and Q1 ended June 30, 2026, and is on track for FY ending March 31, 2027. The financial and operational impact is stated as nil.

Niva Bupa Health Insurance Company Ltd has received approval from the Insurance Regulatory and Development Authority of India (IRDAI) for the appointment of Mr. Ashwani Bhatia as the Chairperson of the Company. This approval is effective from June 03, 2026, following an application made by the company to the IRDAI. The company has formally informed stakeholders about this significant management change.

Niva Bupa Health Insurance Company Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The company reported a Profit After Tax (PAT) of ₹138 crore, marking a significant 93% year-on-year growth. Gross Written Premium (GWP) stood at ₹2,150 crore, an increase of 32%. The retail health business saw robust growth of 47%, pushing its market share to 11.1%. The Claim Settlement Ratio improved to 95.6%, and the Combined Insurance Service Ratio (CISR) improved to 100.2%. Direct Business emerged as the fastest-growing distribution channel.